Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
35 studies found for:    "Pars planitis"
Show Display Options
RSS Create an RSS feed from your search for:
"Pars planitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Condition: Non-infectious Intermediate Uveitis
Interventions: Drug: Myfortic;   Drug: Decortin
2 Active, not recruiting Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis;   Noninfectious Uveitis
Intervention: Drug: triamcinolone acetonide (Triesence®)
3 Completed Retisert and Cataract Surgery in Patients With Severe Uveitis
Conditions: Intermediate Uveitis;   Posterior Uveitis
Intervention: Device: Retisert (fluocinolone acetonide implant)
4 Unknown  Intravitreal Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Interventions: Drug: Intravitreal injection 440mcg;   Drug: Intravitreal injection of sirolimus 880mcg
5 Completed
Has Results
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
Conditions: Intermediate Uveitis;   Posterior Uveitis
Interventions: Drug: Dexamethasone;   Drug: dexamethasone;   Drug: Sham injection
6 Unknown  Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: Sirolimus (rapamycin)
7 Recruiting Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: FAI insert;   Drug: Sham injection
8 Completed Quality of Life in Patients With Intermediate Uveitis
Condition: Macular Edema
Intervention:
9 Completed Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
Conditions: Uveitis, Intermediate;   Macular Edema;   Multiple Sclerosis
Interventions: Drug: Interferon beta;   Drug: Methotrexate
10 Recruiting Safety, Tolerability and Efficacy of Intravitreal LFG316 in Patients With Multifocal Choroiditis and Panuveitis (MCP)
Conditions: Multifocal Choroiditis;   Panuveitis;   Active Vitritis
Interventions: Drug: LFG316;   Drug: Conventional Therapy
11 Completed Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis
Conditions: Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: AEB071
12 Completed Vascular Endothelial Growth Factor (VEGF) in Uveitis
Conditions: Macular Edema, Cystoid;   Uveitis
Intervention:
13 Enrolling by invitation The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
Conditions: Uveitis;   Vasculitis;   Ocular Inflammatory Disease
Intervention:
14 Completed
Has Results
Topical Interferon Gamma for Macular Edema Secondary to Uveitis
Conditions: Anterior Uveitis;   Uveitis
Intervention: Drug: Interferon Gamma-1b
15 Recruiting Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Condition: Uveitis
Interventions: Drug: Placebo;   Drug: Dose 1 gevokizumab;   Drug: Dose 2 gevokizumab
16 Withdrawn A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis
Condition: Uveitis
Intervention: Device: Iontophoresis second generation Eyegate II device
17 Completed Phase III Study in Refractory Behcet's Disease
Condition: Behcet Disease
Interventions: Drug: AIN457;   Drug: Placebo
18 Enrolling by invitation A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
Condition: Uveitis
Intervention: Drug: adalimumab
19 Not yet recruiting Safety &Efficacy of CF101 to Subjects With Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate
Interventions: Drug: CF101;   Drug: Placebo
20 Terminated Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis
Condition: Uveitis
Interventions: Biological: AIN457;   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years